Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study

Part of paid clinical trials in Los Angeles, California.

Sponsor
KidSIM Simulation Program
Study ID
NCT05868239
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 60 Years
Healthy Volunteers
Accepted

Interventions

  • Aerosol box — DEVICE
    The aerosol box is a transparent, plastic cube covering the patient's head and shoulders, with circular access ports on the front of the box allowing for access to manage the airway. An additional four access holes (i.e. two on either side of the box) allow for airway assistants to access the patient airway.

Study Details

Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients infected with SARS-CoV-2 experience unusually high rates of critical illness that needs advanced airway management and intensive care unit admission. Bag-valve-mask (BVM) ventilation, endotracheal Intubation (ETI) and chest compressions are sometimes required for critically ill COVID-19 patients, and may contribute to a high risk of infection amongst Health Care Workers (HCW). To lessen HCW risk during high-risk procedures, a device called an aerosol box has been developed to place over the head of the patient, shielding the provider's face from virus droplets suspended in the air. The purpose of this research study is to better understand how particles disperse during AGMPs, more specifically during the provision of cardiopulmonary resuscitation (CPR). The project team hopes what is learned from the project can help inform infection control measures. This could help make changes to the clinical environment and make it safer for HCW's. The investigators intend to explore how an aerosol box performs in reducing contamination of HCW's who perform critical airway interventions during resuscitation events.

Key Dates

Start date
Sep 1, 2023
Status verified
Aug 2025
Primary completion
Sep 1, 2025
Completion
Dec 1, 2026

Study Design

Enrollment
240 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Aerosol Box
    The team will complete the resuscitation scenario with an Aerosol box placed.
  • No Intervention: No Aerosol Box
    The team will complete the resuscitation scenario without an Aerosol box placed.

Primary Outcome Measure

Percentage of overall excellent CPR [ Time Frame: Immediately after simulated resuscitation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Department of Emergency Medicine, Children's Hospital of Los AngelesLos AngelesCalifornia90027
Todd Chang, MD
[email protected]

Find similar trials in Los Angeles, CA

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
Department of Emergency Medicine, Children's Hospital of Los Angeles· Los Angeles, CA

Related Studies